Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors. [electronic resource]
Producer: 20071012Description: 2325-34 p. digitalISSN:- 0268-1161
- Aldosterone -- pharmacology
- Androstadienes -- pharmacology
- Androstenes -- pharmacology
- Cells, Cultured
- Endothelium, Vascular -- cytology
- Enzyme Activation
- Estradiol -- pharmacology
- Flavonoids -- pharmacology
- Humans
- Medroxyprogesterone Acetate -- pharmacology
- Mifepristone -- pharmacology
- Nitric Oxide -- biosynthesis
- Nitric Oxide Synthase Type III -- drug effects
- Progesterone -- pharmacology
- Receptors, Mineralocorticoid -- drug effects
- Receptors, Progesterone -- drug effects
- Signal Transduction -- drug effects
- Time Factors
- Wortmannin
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.